Discovering New Drug Targets Or Biomarkers for Cancer Treatment
Discovering New Drug Targets Or Biomarkers for Cancer Treatment
Adaptor-related protein complex 1 (AP1 adapter complex) is a protein complex that plays a critical role in the process of protein synthesis in eukaryotic cells. It is composed of several proteins that work together to recognize, bind and transport specific proteins. Under normal circumstances, AP1 adapter complex 1 is a protein complex composed of multiple subunits, including: AP1, AP2, AP3, AP4 and AP5.
The function of AP1 adapter complex 1 is to bind to initiation factors in the protein translation process in cells, thereby enabling RNA polymerase to bind to ribosomes. It is the binding partner of RNA polymerase II (RNA-II), the enzyme responsible for transcribing DNA into RNA. By binding to RNA-II, AP1 adapter complex 1 is able to recognize and bind to a specific region on RNA-II, allowing it to bind to ribosomes and initiate protein synthesis.
The composition and structure of AP1 adapter complex 1 are critical to its function. Multiple research groups have conducted in-depth studies on the structure and function of AP1 adapter complex 1 and proposed some hypotheses. For example, subunits of AP1 adapter complex 1 can bind to specific regions on RNA-II, and different subunits may bind to different regions. In addition, subunits of AP1 adapter complex 1 can interact with each other to form a stable protein complex.
The role of AP1 adapter complex 1 in cancer has also attracted attention. Many studies have shown that the expression level of AP1 adapter complex 1 changes in various cancers and is related to cancer progression and treatment response. For example, expression levels of AP1 adapter complex 1 are positively correlated with progression and treatment response in cancers such as breast, lung, and colon cancer. In addition, AP1 adapter complex 1 is also related to the apoptosis and proliferation of tumor cells. Therefore, AP1 adapter complex 1 may be a potential drug target or biomarker.
Currently, a variety of drugs have been developed to treat cancer, but most of them target specific tumor cell types or specific pathological characteristics. Therefore, discovering new drug targets or biomarkers is of great significance. AP1 adapter complex 1 is a potential drug target or biomarker because it is a key protein expressed in a variety of cancers. By deeply studying the structure and function of AP1 adapter complex 1, new drug targets or biomarkers can be discovered and the treatment of cancer can be promoted.
Protein Name: Adaptor-related Protein Complex 1
More Common Targets
Adaptor-related protein complex 2 | Adaptor-Related Protein Complex 3 | Adaptor-related protein complex 4 | ADAR | ADARB1 | ADARB2 | ADARB2-AS1 | ADAT1 | ADAT2 | ADAT3 | ADCK1 | ADCK2 | ADCK5 | ADCY1 | ADCY10 | ADCY10P1 | ADCY2 | ADCY3 | ADCY4 | ADCY5 | ADCY6 | ADCY7 | ADCY8 | ADCY9 | ADCYAP1 | ADCYAP1R1 | ADD1 | ADD2 | ADD3 | ADD3-AS1 | Adducin | Adenosine A2 receptor | Adenosine deaminase | Adenosine receptor | Adenylate Cyclase | ADGB | ADGB-DT | ADGRA1 | ADGRA2 | ADGRA3 | ADGRB1 | ADGRB2 | ADGRB3 | ADGRB3-DT | ADGRD1 | ADGRD2 | ADGRE1 | ADGRE2 | ADGRE3 | ADGRE4P | ADGRE5 | ADGRF1 | ADGRF2 | ADGRF3 | ADGRF4 | ADGRF5 | ADGRG1 | ADGRG2 | ADGRG3 | ADGRG4 | ADGRG5 | ADGRG6 | ADGRG7 | ADGRL1 | ADGRL1-AS1 | ADGRL2 | ADGRL3 | ADGRL4 | ADGRV1 | ADH1A | ADH1B | ADH1C | ADH4 | ADH5 | ADH5P4 | ADH6 | ADH7 | Adhesion G-protein coupled receptor G1 (isoform a) | ADHFE1 | ADI1 | ADIG | ADIPOQ | ADIPOQ-AS1 | ADIPOR1 | ADIPOR2 | ADIRF | ADK | ADM | ADM-DT | ADM2 | ADM5 | ADNP | ADNP2 | ADO | ADORA1 | ADORA2A | ADORA2A-AS1 | ADORA2B | ADORA3 | ADP-Ribosylation Factor